A novel compound, denosomin, ameliorates spinal cord injury via axonal growth associated with astrocyte‐secreted vimentin
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background and Purpose: In the spinal cord injury (SCI) axon regeneration is inhibited by the glial scar, which contains reactive astrocytes that secrete inhibitory chondroitin sulphate proteoglycan (CSPG). We previously reported that a novel compound, denosomin, promotes axonal growth under degenerative conditions in cultured cortical neurons. In this study, we investigated the effects of denosomin on functional recovery in SCI mice and elucidated the mechanism though which denosomin induces axonal growth in the injured spinal cord. Experimental Approach: D enosomin was administered p.o. for 7 or 14 days to contusion mice. Behavioural evaluations and immunohistochemistry were done. Primary cultured cortical neurons and astrocytes were treated with denosomin to investigate the mechanism of axonal growth facilitation. Key Results: D enosomin improved hind limb motor dysfunction and axonal growth, especially in the 5‐HT‐positive tracts across the scar and increased the density of astrocytes. D enosomin increased astrocyte proliferation, inhibited astrocytic death and increased the expression and secretion of vimentin in cultured astrocytes. Furthermore, vimentin increased axonal outgrowth in cultured neurons, even in the presence of inhibitory CSPG. D enosomin increased the number of vimentin‐expressing astrocytes inside glial scars of SCI mice, and 5‐HT‐positive axonal growth occurred in a vimentin‐associated manner. Conclusion and Implications: D enosomin increased the ratio of astrocytes that secrete vimentin as an axonal growth facilitator, which, we propose enhances axonal growth beyond the glial scar and promotes functional recovery in SCI mice. This study is the first to demonstrate this novel role of vimentin in SCI and drug‐mediated modification of the inhibitory property of reactive astrocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625
Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
McGrath, J., Drummond, G., McLachlan, E., Kilkenny, C., & Wainwright, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00873.x · Cited by 1,592
STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord Injury
Herrmann, J. E., Imura, T., Song, B., Qi, J., Ao, Y., Nguyen, T. K., Korsak, R. A., Takeda, K., Akira, S., & Sofroniew, M. V. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1709-08.2008 · Cited by 958 · cited 2×
“However, several lines of evidence suggest that reactive astrocytes in glial scars may possess important beneficial functions for stabilizing fragile CNS tissue after injury including the restriction of inflammation and the promotion of neuronal survival (Faulkner et al., 2004; Okada et al., 2006; Herrmann et al., 200…”
BackgroundThe bright side of the glial scar in CNS repair
Rolls, A., Shechter, R., & Schwartz, M. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2591 · Cited by 674 · cited 4×
“The promotion and inhibition of axonal growth by reactive astrocytes has previously been well characterized (Silver and Miller, 2004; Okada et al., 2006; Yiu and He, 2006; Rolls et al., 2009; White et al., 2011).”
BackgroundInfluentialVimentin is secreted by activated macrophages
Mor-Vaknin, N., Punturieri, A., Sitwala, K., & Markovitz, D. M. (2003) · Nature Cell Biology · doi:10.1038/ncb898 · Cited by 522
Neuritic regeneration and synaptic reconstruction induced by withanolide A
Kuboyama, T., Tohda, C., & Komatsu, K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706122 · Cited by 339 · cited 2×
“K) as described previously (Kuboyama et al., 2005) with modifications.”
Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)‐induced neurodegeneration
Kuboyama, T., Tohda, C., & Komatsu, K. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04664.x · Cited by 171 · cited 1×
“Sominone is a sapogenin metabolized from withanoside IV, which is one of the constituents of an ayurvedic tonic medicine Ashwagandha (root of Withania somnifera Dunal) (Kuboyama et al., 2006), and is itself a constituent of Ashwagandha (Atta-ur-Rahman et al., 1992).”
BackgroundSelf-citationTohda, C., & Joyashiki, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00313.x · Cited by 62
Self-citation
Cited by
Vimentin Diversity in Health and Disease
Danielsson, F., Peterson, M. K., Caldeira Araújo, H., Lautenschläger, F., & Gad, A. K. B. (2018) · Cells · doi:10.3390/cells7100147 · Cited by 265
Natural Withanolides in the Treatment of Chronic Diseases
White, P. T., Subramanian, C., Motiwala, H. F., & Cohen, M. S. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-41334-1_14 · Cited by 139
“In addition to neuroinflammatory modulation, several withanolides including WS extract, withanosides (particularly withanoside IV and its active metabolite sominone), the synthetic withanolidedenosomin, withanolide A and coagulin Q have all demonstrated important effects on stimulating neurite outgrowth and regenerati…”
BackgroundEffects of Ashwagandha (Roots of Withania somnifera) on Neurodegenerative Diseases
Kuboyama, T., Tohda, C., & Komatsu, K. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00022 · Cited by 127
Tanie, Y., Tanabe, N., Kuboyama, T., & Tohda, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01228 · Cited by 11
“We previously reported that several agents showed axonal growth activity without the alteration at the lesion site (Teshigawara et al., 2013; Tanabe et al., 2018).”
BackgroundSelf-citation
Metadata
- Authors
- Teshigawara, K., Kuboyama, T., Shigyo, M., Nagata, A., Sugimoto, K., Matsuya, Y., & Tohda, C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2013-01-24
- Volume
- 168
- Issue
- 4
- Pages
- 903-919
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1530671225
- Cited by
- 57
- References
- 9
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A novel compound, denosomin, ameliorates spinal cord injury via axonal growth associated with astrocyte‐secreted vimentin. https://app.cochat.ai/papers/10.1111/j.1476-5381.2012.02211.x
- The paper
- Teshigawara, K., Kuboyama, T., Shigyo, M., Nagata, A., Sugimoto, K., Matsuya, Y., & Tohda, C. (2013). A novel compound, denosomin, ameliorates spinal cord injury via axonal growth associated with astrocyte‐secreted vimentin. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2012.02211.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.